Vitamin B12 Deficiency: Recognition and Management

Area of Science:

• Internal Medicine
• Hematology
• Nutritional Science

Background:

• Vitamin B12 deficiency is a prevalent cause of megaloblastic anemia and neuropsychiatric symptoms.
• Routine screening for vitamin B12 deficiency in average-risk adults is not advised.
• Screening is indicated for individuals with specific risk factors.

Purpose of the Study:

• To outline screening recommendations for vitamin B12 deficiency.
• To detail appropriate diagnostic laboratory assessments.
• To describe effective treatment strategies for vitamin B12 deficiency.

Main Methods:

• Review of clinical guidelines and evidence regarding vitamin B12 deficiency screening and management.
• Identification of patient populations with increased risk for deficiency.
• Evaluation of diagnostic laboratory tests including complete blood count, serum vitamin B12, and serum methylmalonic acid.
• Assessment of oral versus intramuscular vitamin B12 treatment efficacy.

Main Results:

• Screening is recommended for patients with risk factors like gastrointestinal surgery, inflammatory bowel disease, long-term metformin or acid-suppressing medication use, vegan diets, or age over 75.
• Initial tests include CBC and serum vitamin B12; serum methylmalonic acid confirms deficiency in ambiguous cases.
• High-dose oral vitamin B12 is as effective as intramuscular administration for correcting anemia and neurological symptoms, though IM offers faster improvement for severe cases.
• Lifelong supplementation is advised for post-bariatric surgery patients.
• Vitamin B12 supplementation does not reduce cardiovascular risk or alter cognitive decline in patients with elevated homocysteine and cardiovascular disease.

Conclusions:

• Targeted screening for vitamin B12 deficiency is crucial in at-risk populations.
• Oral high-dose vitamin B12 is a viable and effective treatment option.
• Supplementation strategies should be tailored based on individual risk factors and disease severity.